-
For most people, the virus is mild — but experts say it can be more severe for infants, young children and older adults.
-
Flu. COVID. RSV. When and how to get vaccinated against them can be confusing. Here are some of the most important things to know.
-
An expert panel for the CDC endorsed the one-time shot for infants born just before or during the RSV season and for those less than 8 months old before the start of the season.
-
AstraZeneca’s drug, to be sold under the brand name Beyfortus, is a laboratory-made version of an antibody that helps the immune system fight off RSV.
-
The newly approved vaccines are expected to be ready in the fall, a time when flu shots and updated COVID-19 shots also will be available.
-
At least 58,000 childern younger than 5 years old are hospitalized each year with RSV infections. A Pfizer vaccine given to pregnant people could help protect their infants from severe RSV illness.
-
The move sets the stage for adults 60 and older to get vaccinated this fall — but first, the CDC must decide if every senior really needs RSV protection or only those considered at high risk.
-
The Vaccines for Children program, which buys more than half the pediatric vaccines in the U.S., may not cover the RSV shot for babies because it’s not technically a vaccine.
-
The illness sends tens of thousands of babies to the hospital each year. If approved, the new injection would be the first broadly available prevention tool.
-
After months of COVID, flu and RSV infections, parents of little kids are kinda losing it. But the data shows kids have always brought home waves of respiratory illness.